Kazakhstan's health ministry. It runs the Comprehensive Plan to Fight Cancer 2023 to 2027, sets the national screening programme, and says cancer treatment for citizens is paid by the state within the guaranteed volume of free medical care.
The Ministry of Health is responsible for the Comprehensive Plan to Fight Cancer in the Republic of Kazakhstan for 2023 to 2027, approved by Government decree No. 874 of 5 October 2023 and set out in a new edition by decree No. 864 of 1 October 2026. The plan follows the Comprehensive Plan for 2018 to 2022 (decree No. 395 of 29 June 2018), during which, it says, cancer mortality fell by 15%, from 78.1 to 66.8 per 100,000. Its five directions are prevention, early diagnosis, specialised treatment, palliative care and rehabilitation, and science and workforce, and its financing table totals 460,670.4 million tenge over five years. Its targets for 2027 are 35% of cancers found at stage 0 or I, radiotherapy for 53% of patients, mortality of 64.5 per 100,000 and five-year survival of 60%. The coordinates are an approximate Astana city point.
The Ministry's order No. ҚР ДСМ-174/2020 sets the target groups for screening: mammography every two years for women aged 40 to 76, cervical cytology every four years for women aged 30 to 74 and a faecal occult blood test every two years for men and women aged 50 to 76, all within the guaranteed volume of free medical care. On 17 September 2026 the Ministry said cancer treatment for citizens is provided at the state's expense, that 150 anticancer medicines are available (102 chemotherapy, 45 targeted and 3 immuno-oncology), that more than 55,000 people a year receive anticancer drug treatment, and that outpatient consultations and tests for suspected cancer follow a "green corridor" with a limit of 18 working days.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Ministry of Health of the Republic of Kazakhstan, including child institutions. 8 works · 16 citations · 100% open access · 0% clinical trials · 0% reviews.
Shares National Scientific Oncology Center (Astana), Kazakh Institute of Oncology and Radiology (KazIOR), Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, International Agency for Research on Cancer (IARC / WHO), Gastric & gastro-oesophageal junction cancer.
Shares Kazakh Institute of Oncology and Radiology (KazIOR), Gastric & gastro-oesophageal junction cancer, Lung cancer (all types), Colorectal cancer.
Shares Kazakh Institute of Oncology and Radiology (KazIOR), Cervical cancer, Breast cancer (all types), Colorectal cancer.
Shares International Atomic Energy Agency: Rays of Hope, Cancer registries and population surveillance, Gastric & gastro-oesophageal junction cancer, Lung cancer (all types).
Shares World Health Organization Cancer Programme, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/